Fujian Aonong Biological Technology Group Incorporation Limited (SHA:603363)
China flag China · Delayed Price · Currency is CNY
2.630
-0.090 (-3.31%)
Nov 17, 2026, 3:00 PM CST

SHA:603363 Revenue

Fujian Aonong Biological Technology Group Incorporation had revenue of 2.50B CNY in the quarter ending September 30, 2026, with 5.18% growth. This brings the company's total for the last twelve months to 9.16B, up 12.11% year-over-year. In the year 2025, Fujian Aonong Biological Technology Group Incorporation had annual revenue of 8.47B, down -3.29%. That makes Fujian Aonong Biological Technology Group Incorporation the 6,340th largest company in the world by revenue and 873rd in China.

Revenue (ttm)
9.16B
Revenue Growth
+12.11%
P/S Ratio
0.79
Revenue / Employee
1.79M
Employees
5,126
Market Cap
7.18B

Revenue Chart

Revenue by Segment

  • Feed and Animal Protection 6.57B 70.8%
  • Feeding 1.57B 16.9%
  • Food 1.09B 11.8%
  • Trading 31.15M 0.3%
  • Others 13.00M 0.1%
Fiscal year ended Dec 31, 2025 See the full SHA:603363 breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20258.47B-287.93M-3.29%
Dec 31, 20248.76B-10.69B-54.97%
Dec 31, 202319.46B-2.16B-9.97%
Dec 31, 202221.61B3.57B19.82%
Dec 31, 202118.04B6.52B56.62%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.